{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:33:03Z","timestamp":1787671983016,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-026-10426-w","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T03:08:52Z","timestamp":1787627332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Noninvasive molecular imaging signatures of histopathological growth patterns in colorectal cancer liver metastases"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-0916","authenticated-orcid":false,"given":"Irina","family":"Vierasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sclafani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Delbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Doumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bohlok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Donckier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Flamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"26","key":"10426_CR1","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3748\/wjg.v28.i26.3101","volume":"28","author":"B Kong","year":"2022","unstructured":"Kong B, Fan Q, Wang X, Zhang Q, Zhang G (2022) Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases. World J Gastroenterol 28(26):3101\u20133111. https:\/\/doi.org\/10.3748\/wjg.v28.i26.3101","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10426_CR2","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41416-022-01859-7","volume":"127","author":"E Latacz","year":"2022","unstructured":"Latacz E, H\u00f6ppener D, Bohlok A, Leduc S, Tabari\u00e8s S, Fern\u00e1ndez Moro C et al (2022) Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br J Cancer 127(6):988\u20131013. https:\/\/doi.org\/10.1038\/s41416-022-01859-7","journal-title":"Br J Cancer"},{"key":"10426_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.102926","volume":"136","author":"G Bregni","year":"2025","unstructured":"Bregni G, Adams R, Bale R, Sclafani F et al (2025) EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases. Cancer Treat Rev 136:102926. https:\/\/doi.org\/10.1016\/j.ctrv.2025.102926","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10426_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40688-x","volume":"14","author":"C Fern\u00e1ndez Moro","year":"2023","unstructured":"Fern\u00e1ndez Moro C, Geyer N, Harrizi S, Hamidi Y, S\u00f6derqvist S et al (2023) An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver. Nat Commun 14(1):5024. https:\/\/doi.org\/10.1038\/s41467-023-40688-x","journal-title":"Nat Commun"},{"key":"10426_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2020.06.010","volume":"71","author":"E Latacz","year":"2020","unstructured":"Latacz E, Van Dam PJ, Vanhove C, Llad\u00f3 L et al (2020) Can medical imaging identify the histopathological growth patterns of liver metastases? Semin Cancer Biol 71:33\u201341. https:\/\/doi.org\/10.1016\/j.semcancer.2020.06.010","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10426_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10585-021-10132-1","volume":"38","author":"MPA Starmans","year":"2021","unstructured":"Starmans MPA, Buisman FE, Renckens M, Willemssen FEJA, van der Voort SR et al (2021) Distinguishing pure histopathological growth patterns of colorectal liver metastases on CT using deep learning and radiomics: a pilot study. Clin Exp Metastasis 38(5):483\u2013494. https:\/\/doi.org\/10.1007\/s10585-021-10132-1","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"10426_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071646","volume":"14","author":"H Tharmaseelan","year":"2022","unstructured":"Tharmaseelan H, Hertel A, Tollens F, Rink J, Wo\u017anicki P, Haselmann V et al (2022) Identification of CT imaging phenotypes of colorectal liver metastases from radiomics signatures\u2014towards assessment of interlesional tumour heterogeneity. Cancers (Basel) 14(7):1646. https:\/\/doi.org\/10.3390\/cancers14071646","journal-title":"Cancers (Basel)"},{"key":"10426_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y et al (2022) Warburg effect in colorectal cancer: the emerging roles in tumour microenvironment and therapeutic implications. J Hematol Oncol 15:160. https:\/\/doi.org\/10.1186\/s13045-022-01358-5","journal-title":"J Hematol Oncol"},{"key":"10426_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26466","author":"A Bohlok","year":"2021","unstructured":"Bohlok A, Duran Derijckere I, Azema H, Donckier V, Van Laethem JL, Demetter P et al (2021) Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases. J Surg Oncol. https:\/\/doi.org\/10.1002\/jso.26466","journal-title":"J Surg Oncol"},{"issue":"1","key":"10426_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-023-01713-1.PMID:36691028;PMCID:PMC9872436","volume":"22","author":"JR Fleischer","year":"2023","unstructured":"Fleischer JR, Schmitt AM, Haas G, Xu X, Zeisberg EM (2023) Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution. Mol Cancer 22(1):17. https:\/\/doi.org\/10.1186\/s12943-023-01713-1.PMID:36691028;PMCID:PMC9872436","journal-title":"Mol Cancer"},{"issue":"3","key":"10426_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10456-019-09669-z","volume":"22","author":"B Galjart","year":"2019","unstructured":"Galjart B, Nierop P, van der Stok EP, van den Braak RRJ, H\u00f6ppener DJ, Daelemans S et al (2019) Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. Angiogenesis 22(3):355\u2013368. https:\/\/doi.org\/10.1007\/s10456-019-09669-z","journal-title":"Angiogenesis"},{"issue":"6","key":"10426_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10585-012-9469-1","volume":"29","author":"GG Van den Eynden","year":"2012","unstructured":"Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB (2012) The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clin Exp Metastasis 29(6):541\u2013549. https:\/\/doi.org\/10.1007\/s10585-012-9469-1","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"10426_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nm.4197","volume":"22","author":"S Frentzas","year":"2016","unstructured":"Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB (2016) Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med 22(11):1294\u20131302. https:\/\/doi.org\/10.1038\/nm.4197","journal-title":"Nat Med"},{"issue":"7","key":"10426_CR14","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41416-018-0015-z","volume":"118","author":"C Cremolini","year":"2018","unstructured":"Cremolini C, Milione M, Marmorino F, Morano F, Zucchelli G, Mennitto A (2018) Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials. Br J Cancer 118(7):955\u2013965. https:\/\/doi.org\/10.1038\/s41416-018-0015-z. (Epub 2018)","journal-title":"Br J Cancer"},{"issue":"1","key":"10426_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7150\/thno.13242.PMID:26722375;PMCID:PMC4679356","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen H, Niu G, Wu H, Chen X (2016) Clinical application of radiolabeled RGD peptides for PET imaging of integrin \u03b1v\u03b23. Theranostics 6(1):78\u201392. https:\/\/doi.org\/10.7150\/thno.13242.PMID:26722375;PMCID:PMC4679356","journal-title":"Theranostics"},{"key":"10426_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020070","volume":"2","author":"R Haubner","year":"2005","unstructured":"Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M et al (2005) Noninvasive visualization of the activated \u03b1v\u03b23 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD. PLoS Med 2:e70. https:\/\/doi.org\/10.1371\/journal.pmed.0020070","journal-title":"PLoS Med"},{"issue":"1","key":"10426_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2967\/jnumed.107.045864","volume":"49","author":"AJ Beer","year":"2008","unstructured":"Beer AJ, Lorenzen S, Metz S, Herrmann K, Watzlowik P, Wester HJ, Peschel C, Lordick F, Schwaiger M (2008) Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG. J Nucl Med 49(1):22\u201329. https:\/\/doi.org\/10.2967\/jnumed.107.045864. (Epub 2007 Dec 12 PMID: 18077538)","journal-title":"J Nucl Med"},{"key":"10426_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00259-011-1778-0","volume":"38","author":"PA Knetsch","year":"2011","unstructured":"Knetsch PA, Petrik M, Griessinger CM et al (2011) [68Ga]NODAGA-RGD for imaging \u03b1v\u03b23 integrin expression. Eur J Nucl Med Mol Imaging 38:1303\u20131312. https:\/\/doi.org\/10.1007\/s00259-011-1778-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10426_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/MNM.0000000000001363","volume":"42","author":"MY Zhang","year":"2021","unstructured":"Zhang MY, Jiang HJ, Jiang H, Zhang RJ, Wang ZC (2021) Micro-positron emission tomography imaging of angiogenesis based on 18F-RGD for assessing liver metastasis of colorectal cancer. Nucl Med Commun 42(5):509\u2013516. https:\/\/doi.org\/10.1097\/MNM.0000000000001363","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10426_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1349-7006.2010.01763.x","volume":"102","author":"B Paudyal","year":"2011","unstructured":"Paudyal B, Paudyal P, Oriuchi N, Hanaoka H, Tominaga H, Endo K (2011) Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts. Cancer Sci 102(1):117\u2013121. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01763.x","journal-title":"Cancer Sci"},{"issue":"11","key":"10426_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115373","volume":"26","author":"H Karimi","year":"2025","unstructured":"Karimi H, Lee S, Xu W, Langhans SA, Johnson DK, Stauff E, Kecskemethy HH, Averill LW, Yue X (2025) Advances in molecular imaging of VEGFRs: innovations in imaging and therapeutics. Int J Mol Sci 26(11):5373. https:\/\/doi.org\/10.3390\/ijms26115373","journal-title":"Int J Mol Sci"},{"key":"10426_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.966","volume":"195","author":"P Vermeulen","year":"2001","unstructured":"Vermeulen P, Colpaert C, Salgado R, Royers R, Hellemans H, Van den Heuvel E et al (2001) Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195:336\u2013342. https:\/\/doi.org\/10.1002\/path.966","journal-title":"J Pathol"},{"issue":"Suppl 2","key":"10426_CR23","doi-asserted-by":"publisher","first-page":"129S","DOI":"10.2967\/jnumed.107.045914","volume":"49","author":"KA Krohn","year":"2008","unstructured":"Krohn KA, Link JM, Mason RP (2008) Molecular imaging of hypoxia. J Nucl Med 49(Suppl 2):129S-S148. https:\/\/doi.org\/10.2967\/jnumed.107.045914. (PMID: 18523070)","journal-title":"J Nucl Med"},{"issue":"2","key":"10426_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.hbpd.2019.03.010","volume":"18","author":"M Zhang","year":"2019","unstructured":"Zhang M, Zhang R, Jiang H, Jiang H, Xu H, Pan W et al (2019) 18F-fluoromisonidazole positron emission tomography may be applicable in the evaluation of colorectal cancer liver metastasis. Hepatobiliary Pancreat Dis Int 18(2):164\u2013172. https:\/\/doi.org\/10.1016\/j.hbpd.2019.03.010","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10426_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.606210","volume":"11","author":"S Lee","year":"2021","unstructured":"Lee S, Tebbutt N, Gan H, Liu Z, Sachinidis J, Pathmaraj K et al (2021) Evaluation of 18F-FMISO PET and 18F-FDG PET scans in assessing the therapeutic response of patients with metastatic colorectal cancer treated with anti-angiogenic therapy. Front Oncol 11:606210. https:\/\/doi.org\/10.3389\/fonc.2021.606210","journal-title":"Front Oncol"},{"key":"10426_CR26","doi-asserted-by":"publisher","DOI":"10.31487\/nl.crio.2020.01.01","author":"K Laws","year":"2020","unstructured":"Laws K, Murray G, Kerr K, McKiddie J et al (2020) Hypoxia PET\/CT and colorectal cancer: a case report. J Case Rep. https:\/\/doi.org\/10.31487\/nl.crio.2020.01.01","journal-title":"J Case Rep"},{"issue":"3","key":"10426_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2025.100871.PMID:41631002;PMCID:PMC12860988","volume":"5","author":"D Swaroop","year":"2025","unstructured":"Swaroop D, Smith J, Van Zuykelom J, Noor A, Wagner RA, Vu T, Lee S, Heriot AG, Loveday B, Waldeck K, Roselt PD, Blyth B, Donnelly PS, Hollande F (2025) Carbonic anhydrase-IX is a specific and sensitive theragnostic target for imaging and radioimmunotherapy in metastatic colorectal cancer. Gastro Hep Adv 5(3):100871. https:\/\/doi.org\/10.1016\/j.gastha.2025.100871.PMID:41631002;PMCID:PMC12860988","journal-title":"Gastro Hep Adv"},{"key":"10426_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","volume":"25","author":"B Shuch","year":"2024","unstructured":"Shuch B, Pantuck AJ, Bernhard JC et al (2024) [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol 25:1277\u20131287","journal-title":"Lancet Oncol"},{"key":"10426_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07619-y","author":"C Rousseau","year":"2025","unstructured":"Rousseau C, Heyman MF, Ferrer L, Rauscher A et al (2025Nov 1) Prospective pilot study with [89Zr]Zr-girentuximab PET\/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE). Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-025-07619-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"24","key":"10426_CR30","first-page":"7075","volume":"60","author":"C Wykoff","year":"2000","unstructured":"Wykoff C, Beasley N, Watson P, Turner K et al (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Can Res 60(24):7075\u20137083","journal-title":"Can Res"},{"key":"10426_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2967\/jnumed.113.126615","volume":"55","author":"S Carlin","year":"2014","unstructured":"Carlin S, Zhang H, Reese MM, Ramos NN et al (2014) A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. J Nucl Med 55:515\u2013521. https:\/\/doi.org\/10.2967\/jnumed.113.126615","journal-title":"J Nucl Med"},{"issue":"5","key":"10426_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2967\/jnumed.123.267175","volume":"65","author":"MS Hofman","year":"2024","unstructured":"Hofman MS, Tran B, Feldman DR, Pokorska-Bocci A et al (2024) First-in-human safety, imaging, and dosimetry of a carbonic anhydrase IX-targeting peptide, [68Ga]Ga-DPI-4452, in patients with clear cell renal cell carcinoma. J Nucl Med 65(5):740\u20133. https:\/\/doi.org\/10.2967\/jnumed.123.267175","journal-title":"J Nucl Med"},{"key":"10426_CR33","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.7150\/thno.77552","volume":"12","author":"A Giguelay","year":"2022","unstructured":"Giguelay A, Turtoi E, Khelaf L et al (2022) The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Theranostics 12:7624\u20137639. https:\/\/doi.org\/10.7150\/thno.77552","journal-title":"Theranostics"},{"issue":"9","key":"10426_CR34","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A et al (2018) Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med 59(9):1415\u20131422. https:\/\/doi.org\/10.2967\/jnumed.118.210443","journal-title":"J Nucl Med"},{"issue":"13","key":"10426_CR35","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1007\/s00259-022-05860-1","volume":"49","author":"K Dendl","year":"2022","unstructured":"Dendl K, Dittmann H, Grunwald V, Stief C, Heck MM, Eiber M et al (2022) Comparison of [68Ga]FAPI and [18F]FDG PET\/CT in patients with various cancers: a prospective pilot study. Eur J Nucl Med Mol Imaging 49(13):4296\u20134306. https:\/\/doi.org\/10.1007\/s00259-022-05860-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10426_CR36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D et al (2018) A tumour-imaging method targeting cancer-associated fibroblasts. J Nucl Med 59(9):1423\u20131429. https:\/\/doi.org\/10.2967\/jnumed.118.210435","journal-title":"J Nucl Med"},{"issue":"22","key":"10426_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225744","volume":"13","author":"T Lindner","year":"2021","unstructured":"Lindner T, Giesel FL, Kratochwil C, Serfling SE (2021) Radioligands targeting fibroblast activation protein (FAP). Cancers (Basel) 13(22):5744. https:\/\/doi.org\/10.3390\/cancers13225744","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10426_CR38","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/jcm12061488","volume":"12","author":"Z Cheng","year":"2023","unstructured":"Cheng Z, Wang S (2023) FAPI PET\/CT in diagnostic and treatment management of colorectal cancer: review of current research status. J Clin Med 12(6):1488. https:\/\/doi.org\/10.3390\/jcm12061488","journal-title":"J Clin Med"},{"issue":"13","key":"10426_CR39","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","volume":"48","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M et al (2021) Head-to-head intra-individual comparison of biodistribution and tumour uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging 48(13):4377\u20134385. https:\/\/doi.org\/10.1007\/s00259-021-05307-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10426_CR40","doi-asserted-by":"publisher","first-page":"1185401","DOI":"10.3389\/fonc.2023.1185401","volume":"13","author":"X Lin","year":"2023","unstructured":"Lin X, Li Y, Zhang L et al (2023) Diagnostic value of [68Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [18F]F-FDG PET\/CT. Front Oncol 13:1185401. https:\/\/doi.org\/10.3389\/fonc.2023.1185401","journal-title":"Front Oncol"},{"issue":"9","key":"10426_CR41","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","volume":"26","author":"KM Pabst","year":"2025","unstructured":"Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T et al (2025) [68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial. Lancet Oncol 26(9):1204\u20131214. https:\/\/doi.org\/10.1016\/S1470-2045(25)00299-2","journal-title":"Lancet Oncol"},{"issue":"1","key":"10426_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2967\/jnumed.124.269002","volume":"66","author":"TA Hope","year":"2025","unstructured":"Hope TA, Calais J, Goenka AH, Haberkorn U, Konijnenberg M, McConathy J et al (2025) SNMMI procedure standard\/EANM practice guideline for fibroblast activation protein (FAP) PET. J Nucl Med 66(1):26\u201333. https:\/\/doi.org\/10.2967\/jnumed.124.269002","journal-title":"J Nucl Med"},{"issue":"1","key":"10426_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01853-w","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Pang Y, Zhou Y, Chen J, Fu H, Guo W et al (2024) Antitumour efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade. Signal Transduct Target Ther 9(1):142. https:\/\/doi.org\/10.1038\/s41392-024-01853-w","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10426_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y et al (2021) Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med 27(1):152\u2013164. https:\/\/doi.org\/10.1038\/s41591-020-1131-x","journal-title":"Nat Med"},{"issue":"52","key":"10426_CR45","doi-asserted-by":"publisher","first-page":"eaba0759","DOI":"10.1126\/sciimmunol","volume":"5","author":"JC Lee","year":"2020","unstructured":"Lee JC, Mehdizadeh S, Smith J, Young A et al (2020) Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol. 5(52):eaba0759. https:\/\/doi.org\/10.1126\/sciimmunol","journal-title":"Sci Immunol."},{"issue":"3","key":"10426_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.385","volume":"5","author":"G Garcia-Vici\u00e9n","year":"2024","unstructured":"Garcia-Vici\u00e9n G, Ruiz N, Micke P, Ruffinelli J, Mils K, Ba\u00f1uls M et al (2024) The histological growth patterns in liver metastases from colorectal cancer display differences in lymphoid, myeloid, and mesenchymal cells. MedComm 5(3):e385. https:\/\/doi.org\/10.1002\/mco2.385","journal-title":"MedComm"},{"issue":"10","key":"10426_CR47","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/s41416-020-0788-2","volume":"122","author":"S Stremitzer","year":"2020","unstructured":"Stremitzer S, Vermeulen PB, Graver S, Kockx M, Dirix L, Yang D et al (2020) Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. Br J Cancer 122(10):1518\u20131524. https:\/\/doi.org\/10.1038\/s41416-020-0788-2","journal-title":"Br J Cancer"},{"key":"10426_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.humpath.2023.02.004","volume":"139","author":"Y Takahashi","year":"2023","unstructured":"Takahashi Y, Matsuo K, Shiozawa T, Suzuki K, Shimizu H, Tanaka K (2023) Prognostic implications of histologic growth patterns and tumour budding in colorectal liver metastases. Hum Pathol 139:134\u2013145. https:\/\/doi.org\/10.1016\/j.humpath.2023.02.004","journal-title":"Hum Pathol"},{"issue":"5","key":"10426_CR49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00262-019-02469-2","volume":"69","author":"J Liang","year":"2020","unstructured":"Liang J, Xi S, Shao Q, Yuan Y, Li B, Zheng Y et al (2020) Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy. Cancer Immunol Immunother 69(5):873\u2013884. https:\/\/doi.org\/10.1007\/s00262-019-02469-2","journal-title":"Cancer Immunol Immunother"},{"key":"10426_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/curroncol32090493","volume":"32","author":"D Cao","year":"2025","unstructured":"Cao D, Zhou A (2025) Tumour immune microenvironment and current status of immune checkpoint inhibitor therapy in colorectal cancer liver metastasis. Curr Oncol 32:493. https:\/\/doi.org\/10.3390\/curroncol32090493","journal-title":"Curr Oncol"},{"issue":"2","key":"10426_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41416-020-0852-y","volume":"123","author":"D H\u00f6ppener","year":"2020","unstructured":"H\u00f6ppener D, Nierop PMH, Hof J, Sideras K, Zhou G, Visser L et al (2020) Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis. Br J Cancer 123(2):196\u2013206. https:\/\/doi.org\/10.1038\/s41416-020-0852-y","journal-title":"Br J Cancer"},{"issue":"6","key":"10426_CR52","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1053\/j.semnuclmed.2020.06.005","volume":"50","author":"N Pandit-Taskar","year":"2020","unstructured":"Pandit-Taskar N, Postow MA (2020) Immune-directed molecular imaging biomarkers. Semin Nucl Med 50(6):584\u2013603. https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.06.005","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10426_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2967\/jnumed.120.254607","volume":"62","author":"JW Seo","year":"2021","unstructured":"Seo JW, Tavar\u00e9 R, Mahakian LM, Lepin EJ, Makela AV, Phillips EA et al (2021) CD8 PET imaging of tumour-infiltrating T cells in immune-competent mice using a novel 64Cu-labeled minibody. J Nucl Med 62(5):802\u2013807. https:\/\/doi.org\/10.2967\/jnumed.120.254607","journal-title":"J Nucl Med"},{"issue":"1","key":"10426_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12885-024-11869-8.PMID:38233811;PMCID:PMC10795256","volume":"24","author":"C Takasu","year":"2024","unstructured":"Takasu C, Morine Y, Yoshikawa K, Nakao T, Tokunaga T, Nishi M, Kashihara H, Wada Y, Yoshimoto T, Shimada M (2024) Role of stromal PD-L1 expression in colorectal liver metastasis. BMC Cancer 24(1):97. https:\/\/doi.org\/10.1186\/s12885-024-11869-8.PMID:38233811;PMCID:PMC10795256","journal-title":"BMC Cancer"},{"issue":"6","key":"10426_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2967\/jnumed.124.268289.PMID:40306967;PMCID:PMC12175994","volume":"66","author":"AS Parihar","year":"2025","unstructured":"Parihar AS, Pant N, Heidari P, Fong L, Iravani A (2025) Approaches to imaging immune activation using PET. J Nucl Med 66(6):839\u2013847. https:\/\/doi.org\/10.2967\/jnumed.124.268289.PMID:40306967;PMCID:PMC12175994","journal-title":"J Nucl Med"},{"issue":"5","key":"10426_CR56","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2967\/jnumed.121.262485","volume":"63","author":"MD Farwell","year":"2022","unstructured":"Farwell MD, Gamache RF, Babazada H, Hellmann MD, Harding JJ, Korn R, Mascioni A, Le W, Wilson I, Gordon MS, Wu AM, Ulaner GA, Wolchok JD, Postow MA, Pandit-Taskar N (2022) CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody. J Nucl Med 63(5):720\u2013726. https:\/\/doi.org\/10.2967\/jnumed.121.262485","journal-title":"J Nucl Med"},{"issue":"11","key":"10426_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmogo.2026.100314.PMID:41809060;PMCID:PMC12969389","volume":"2","author":"LB Callesen","year":"2026","unstructured":"Callesen LB, Spindler KG (2026) Systematic review and meta-analysis of studies assessing circulating tumor DNA kinetics in metastatic colorectal cancer. ESMO Gastrointest Oncol 2(11):100314. https:\/\/doi.org\/10.1016\/j.esmogo.2026.100314.PMID:41809060;PMCID:PMC12969389","journal-title":"ESMO Gastrointest Oncol"},{"key":"10426_CR58","doi-asserted-by":"publisher","first-page":"103406","DOI":"10.1016\/j.eclinm.2025.103406","volume":"87","author":"L Wullaert","year":"2025","unstructured":"Wullaert L, Jansen MPHM, Kraan J et al (2025) Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study. EClinicalMedicine. 87:103406. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103406","journal-title":"EClinicalMedicine."},{"issue":"2","key":"10426_CR59","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1245\/s10434-025-18696-6","volume":"33","author":"MJG Bond","year":"2026","unstructured":"Bond MJG, Bolhuis K, Linders TC, Mijnals C, van den Broek D, May AM, Fijneman RJA, Punt CJA, Swijnenburg RJ (2026) Prognostic value of circulating tumor DNA for recurrence and survival in patients undergoing local treatment for initially unresectable RAS\/RAF mutated colorectal cancer liver metastases. Ann Surg Oncol 33(2):1835\u20131843. https:\/\/doi.org\/10.1245\/s10434-025-18696-6","journal-title":"Ann Surg Oncol"},{"key":"10426_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-024-10319-w","volume":"42","author":"E Latacz","year":"2025","unstructured":"Latacz E, Verheul SML, Sillis Y et al (2025) Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface. Clin Exp Metastasis 42:1. https:\/\/doi.org\/10.1007\/s10585-024-10319-w","journal-title":"Clin Exp Metastasis"},{"issue":"5","key":"10426_CR61","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10585-024-10279-1","volume":"41","author":"S Leduc","year":"2024","unstructured":"Leduc S, Nguyen HL, Richard F et al (2024) Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases. Clin Exp Metastasis 41(5):699\u2013705. https:\/\/doi.org\/10.1007\/s10585-024-10279-1","journal-title":"Clin Exp Metastasis"},{"key":"10426_CR62","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1007\/s10620-021-07089-w","volume":"67","author":"HB Thomaides-Brears","year":"2022","unstructured":"Thomaides-Brears HB, Alkhouri N, Allende D et al (2022) Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis. Dig Dis Sci 67:3366\u20133394. https:\/\/doi.org\/10.1007\/s10620-021-07089-w","journal-title":"Dig Dis Sci"},{"key":"10426_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05559-z","author":"L Skrip","year":"2024","unstructured":"Skrip L, Moosburner S, Tang P et al (2024) Viscoelastic properties of colorectal liver metastases reflect tumour cell viability. J Transl Med. https:\/\/doi.org\/10.1186\/s12967-024-05559-z","journal-title":"J Transl Med"},{"key":"10426_CR64","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2967\/jnumed.106.035774","volume":"48","author":"M Soret","year":"2007","unstructured":"Soret M, Bacharach SL, Buvat I (2007) Partial-volume effect in PET tumor imaging. J Nucl Med 48:932\u2013945","journal-title":"J Nucl Med"},{"key":"10426_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-022-00487-7","volume":"9","author":"A Braune","year":"2022","unstructured":"Braune A, Oehme L, Freudenberg R, Hofheinz F, Van Den Hoff J, Kotzerke J et al (2022) Comparison of image quality and spatial resolution between 18F, 68Ga, and 64Cu phantom measurements using a digital Biograph Vision PET\/CT. EJNMMI Phys 9:1\u201314","journal-title":"EJNMMI Phys"},{"key":"10426_CR66","first-page":"1974","volume":"65","author":"H Zhang","year":"2024","unstructured":"Zhang H, Ren C, Liu Y, Yan X, Liu M, Hao Z et al (2024) Performance characteristics of a new generation 148-cm axial field-of-view uMI Panorama GS PET\/CT system. J Nucl Med 65:1974\u20131982","journal-title":"J Nucl Med"},{"key":"10426_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-024-00681-9","volume":"11","author":"L Maris","year":"2024","unstructured":"Maris L, G\u00f6ker M, Debacker J, De Man K, Van Den Broeck B, Van Dorpe J et al (2024) Co-registration of high-resolution specimen PET-CT with histopathology. EJNMMI Phys 11:1\u201313","journal-title":"EJNMMI Phys"},{"key":"10426_CR68","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.2967\/jnumed.116.173708","volume":"57","author":"F Orlhac","year":"2016","unstructured":"Orlhac F, Th\u00e9z\u00e9 B, Soussan M, Boisgard R, Buvat I (2016) Multiscale texture analysis: from PET to histology. J Nucl Med 57:1823\u20131828","journal-title":"J Nucl Med"},{"key":"10426_CR69","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ae241a","volume":"70","author":"J Nuyts","year":"2025","unstructured":"Nuyts J, Defrise M, Morel C, Lecoq P (2025) How the sensitivity of TOF-PET depends on the interplay between the temporal and spatial detector resolutions and the resolution required for the imaging task. Phys Med Biol 70:245001","journal-title":"Phys Med Biol"},{"key":"10426_CR70","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/cmar.s511796","volume":"17","author":"L Wu","year":"2025","unstructured":"Wu L, Ding N, Ji Y, Zhang Y, Li M, Shen J, Hu H, Jin L, Yin S (2025) Habitat analysis in tumor imaging: advancing precision medicine through radiomic subregion segmentation. Cancer Manag Res 17:731\u2013741. https:\/\/doi.org\/10.2147\/cmar.s511796","journal-title":"Cancer Manag Res"},{"key":"10426_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.689509","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ma L-Y, Yin X-P, Gao B-L (2022) Radiomics and radiogenomics in evaluation of colorectal cancer liver metastasis. Front Oncol 11:689509. https:\/\/doi.org\/10.3389\/fonc.2021.689509","journal-title":"Front Oncol"},{"key":"10426_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-024-00670-2","author":"H Zhao","year":"2024","unstructured":"Zhao H, Su Y, Wang Y, Lyu Z, Xu P, Gu W, Tian L, Fu P (2024) Using tumor habitat-derived radiomic analysis during pretreatment 18F-FDG PET for predicting KRAS\/NRAS\/BRAF mutations in colorectal cancer. Cancer Imaging. https:\/\/doi.org\/10.1186\/s40644-024-00670-2","journal-title":"Cancer Imaging"},{"issue":"8","key":"10426_CR73","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2967\/jnumed.122.265622","volume":"64","author":"L Zhao","year":"2023","unstructured":"Zhao L, Wen X, Xu W, Pang Y, Sun L, Wu X et al (2023) Clinical evaluation of 68Ga-FAPI-RGD for imaging of fibroblast activation protein and integrin \u03b1v\u03b23 in various cancer types. J Nucl Med 64(8):1210\u20131217. https:\/\/doi.org\/10.2967\/jnumed.122.265622","journal-title":"J Nucl Med"},{"key":"10426_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07625-0","author":"J Zang","year":"2025","unstructured":"Zang J, Cheng H, Luo Y et al (2025) First-in-human study of a novel bifunctional PET tracer [68Ga]Ga-DOTA-NI-FAPI-04 targeting FAP and hypoxia. Eur J Nucl Med Mol Imaging. https:\/\/doi.org\/10.1007\/s00259-025-07625-0","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10426_CR75","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00259-023-06183-7","volume":"50","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Mei C, Xu D, Yang F, Yang M, Bi L, Mao J, Pang P, Li D (2023) Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer. Eur J Nucl Med Mol Imaging 50(8):2305\u20132318. https:\/\/doi.org\/10.1007\/s00259-023-06183-7. (Epub 2023 Mar 14 PMID: 36914753)","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10426_CR76","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12967-024-05298-1","volume":"22","author":"G Zhang","year":"2024","unstructured":"Zhang G, Xiao Y, Tan J et al (2024) Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma. J Transl Med 22:543. https:\/\/doi.org\/10.1186\/s12967-024-05298-1","journal-title":"J Transl Med"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-026-10426-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-026-10426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:08:12Z","timestamp":1787670492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-026-10426-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":76,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["10426"],"URL":"https:\/\/doi.org\/10.1007\/s10585-026-10426-w","relation":{},"ISSN":["1573-7276"],"issn-type":[{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate and publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"44"}}